The Lantz Family
#ftgf
#carolinestrong
#ftgf
#carolinestrong
How she spent most of the time inpatient.
Rashes from the antibody leaving her system.
One shot per day for 7 days post-inpatient treatment.
Recovering on the couch with her BFF, Hank.
November 2017: diagnosed with Stage IV, High-Risk Neuroblastoma; Nov 2017-April 2019: completed standard treatment protocol / no evidence of disease; April 2019-April 2021: enrolled in/completed DFMO clinical trial; April 2022: RELAPSE; April 2022-June 2023: completed relapse treatment protocol / no evidence of disease (again); June 2023-June 2024: enrolled in “compassionate use” high-dose DFMO clinical trial; June 2024: RELAPSE #2